| 2D Structure | |
| CID | 5281643 |
| Target | AKR1B1 , Chain A, 2 , DLD , euchromatic histone , GAA , MPI , OPRD1 , OPRK1 , OPRM1 , PF3D7_0932300 , Tb927.3.3270 |
| IUPAC Name | 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one |
| InChI | InChI=1S/C21H20O12/c22-6-13-15(27)17(29)18(30)21(32-13)33-20-16(28)14-11(26)4-8(23)5-12(14)31-19(20)7-1-2-9(24)10(25)3-7/h1-5,13,15,17-18,21-27,29-30H,6H2/t13-,15+,17+,18-,21+/m1/s1 |
| InChI Key | OVSQVDMCBVZWGM-DTGCRPNFSA-N |
| Canonical SMILES | C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OC4C(C(C(C(O4)CO)O)O)O)O)O |
| Isomeric SMILES | C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O[C@H]4[C@@H]([C@H]([C@H]([C@H](O4)CO)O)O)O)O)O |
| Molecular Formula | C21H20O12 |
| Molecular Weight | 464.4 |
| synonyms | ['Hyperoside', '482-36-0', 'Hyperin', 'Hyperosid', 'Hyperozide', 'Quercetin-3-O-galactoside', 'Quercetin-3-galactoside', 'quercetin galactoside', 'Quercetin 3-O-beta-D-galactopyranoside', 'quercetin 3-O-galactoside', 'Quercetin 3-beta-D-galactopyranoside', 'NSC 407304', 'UNII-8O1CR18L82', 'CCRIS 9339', 'CHEBI:67486', '8O1CR18L82', 'EINECS 207-580-6', 'Quercetin 3-O-beta-D-galactoside', '2-(3,4-Dihydroxyphenyl)-3-(beta-D-galactopyranosyloxy)-5,7-dihydroxy-4H-1-benzopyran-4-one', 'HYPEROSIDE (USP-RS)', 'HYPEROSIDE [USP-RS]', 'NSC-407304', '2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl beta-D-galactopyranoside', '4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3-(beta-D-galactopyranosyloxy)-5,7-dihydroxy-', "HYPEROSIDE (CONSTITUENT OF ST. JOHN'S WORT)", 'HYPEROSIDE (CONSTITUENT OF HAWTHORN LEAF WITH FLOWER)', '2-(3,4-dihydroxyphenyl)-3-(alpha-D-galactopyranosyloxy)-5,7-dihydroxy-4H-1-benzopyran-4-one', '207-580-6', 'Quercetin 3-galactoside', 'Quercetin 3-D-galactoside', 'Hyperasid', 'QUERCETIN 3-B-D-GALACTOSIDE', 'Jyperin', 'MFCD00016933', '2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4H-chromen-4-one', 'CHEMBL251254', '2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one', 'Quercetin 3-.beta.-D-galactopyranoside', 'Isoquercitrin', "3,3',4',5,7-Pentahydroxyflavone 3-D-galactoside", '4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3-(.beta.-D-galactopyranosyloxy)-5,7-dihydroxy-', '2-[3,4-bis(oxidanyl)phenyl]-3-[(2S,3R,4S,5R,6R)-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-5,7-bis(oxidanyl)chromen-4-one', 'p Hyperin', 'Quercetin 3-O-.beta.-D-galactopyranoside', 'Hyperoside (Standard)', 'BIDD:PXR0057', 'MLS000759538', 'jm5b01461, Compound 84', 'MEGxp0_000392', 'SCHEMBL1250514', 'ACon1_000623', 'HY-N0452R', 'BDBM429266', 'DTXSID501028789', 'HMS2051H17', 'HY-N0452', 'BDBM50241367', 'MSK000529', 's5453', 'AKOS015896780', 'CCG-100970', 'MQ08114', 'NC00220', 'NCGC00168902-03', '2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one', 'AS-56199', 'SMR000466394', '1ST000529', 'QUERCETIN 3-O-.BETA.-D-GALACTOSIDE', 'CS-0008982', 'NS00079301', 'Quercetin 3-D-galactoside, >=97.0% (HPLC)', 'AB00639910-03', 'Hyperoside, primary pharmaceutical reference standard', 'Q5242815', 'BRD-K84955386-001-01-1', "3-O-b-D-Galactopyranosyloxy-3',4',5,7-tetrahydroxyflavone", "HYPEROSIDE (CONSTITUENT OF ST. JOHN'S WORT) [DSC]", 'Hyperoside, United States Pharmacopeia (USP) Reference Standard', '2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl hexopyranoside #', '2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-((2S,4R,5R)-3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-chromen-4-one', '2-(3,4-DIHYDROXYPHENYL)-3-(.BETA.-D-GALACTOPYRANOSYLOXY)-5,7-DIHYDROXY-4H-1-BENZOPYRAN-4-ONE', '2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4H-chromen-4-one', 'Hyperoside;2-(3,4-Dihydroxyphenyl)-3-(b-D-galactopyranosyloxy)-5,7-dihydroxy-4H-1-benzopyran-4-one;Hyperin', 'J6O'] |
From Pubchem